Vanguard Group’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Vanguard Group’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-872,459	Closed	-$1.05M	–	4538
2023 Q4	$1.05M	Sell	872,459 -30,205	-3%	-$32.6K	﹤0.01%	3816
2023 Q3	$778K	Sell	902,664 -2,507	-0.3%	-$2.75K	﹤0.01%	3920
2023 Q2	$1.09M	Buy	905,171 +24,081	+3%	+$120K	﹤0.01%	3875
2023 Q1	$7.7M	Buy	881,090 +428,064	+94%	+$3.96M	﹤0.01%	3084
2022 Q4	$3.62M	Buy	453,026 +15,280	+3%	+$95.9K	﹤0.01%	3443
2022 Q3	$2.14M	Hold	437,746	–	–	﹤0.01%	3708
2022 Q2	$2.43M	Sell	437,746 -83,287	-16%	-$286K	﹤0.01%	3724
2022 Q1	$2.64M	Buy	521,033 +13,758	+3%	+$110K	﹤0.01%	3842
2021 Q4	$6.53M	Buy	507,275 +116,731	+30%	+$1.67M	﹤0.01%	3464
2021 Q3	$5.84M	Buy	390,544 +26,216	+7%	+$447K	﹤0.01%	3554
2021 Q2	$5.66M	Buy	+364,328	New	+$6.38M	﹤0.01%	3531

Vanguard Group's RAIN Position: Q1 2024 in Review

Vanguard Group sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 872,459 shares — an estimated $1.05M sold.

Vanguard Group first reported a position in RAIN in Q2 2021 and held it in 11 quarters. The position peaked at $7.7M in Q1 2023. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Vanguard Group reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 872,459 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $1.05M.
Vanguard Group first reported a position in Rain Oncology Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Vanguard Group's Rain Oncology Inc. Common Stock position peaked at $7.7M in Q1 2023.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.